GGrantIndex
Sort

53,477 grants matching addiction

Validation of a Prenatal Alcohol and Drug Screening Tool

$484,475
Mary Anne Armstrong · Kaiser Foundation Health Plan · R01 · FY2007 · AA

Glutamatergic compounds for treating drug addiction: Preclinical models

$484,475
Eliot Gardner · National Institute On Drug Abuse · ZIA · FY2015 · DA

DRUG DEPENDENCE CLINICAL RESEARCH PROGRAM

$484,389
University Of California San Francisco · P30 · FY2000 · DA

A Reinforcement-Based Therapeutic Workplace

$484,382
Johns Hopkins University · R01 · FY2003 · DA

Role of CaMKII in memory storage

$484,375
Leslie C. Griffith · Brandeis University · R56 · FY2016 · NS

Discovery and development of nociceptin receptor ligands in alcohol dependence

$484,358
Claes Robert Wahlestedt · Scripps Florida · R01 · FY2009 · AA

Incentives in Public Addiction Treatment: Testing Design and Enhancing Impact

$484,284
Sharon Reif · Brandeis University · R01 · FY2015 · DA

Maintaining Nonsmoking

$484,110
Sharon M. Hall · University Of California, San Francisco · R01 · FY2012 · DA

Pathways ot long-term abstinence:Self-help processes

$484,024
Alexandre B Laudet · National Development And Research Institutes, Inc. · R01 · FY2006 · DA

Therapeutic Communities: A Three Country Comparison

$483,990
David Kressel · National Development And Research Institutes, Inc. · R01 · FY2009 · DA

University of Pittsburgh Collaboration in Addiction Training Scholars (PittCATS) Program

$483,950
Jane M Liebschutz · University Of Pittsburgh At Pittsburgh · K12 · FY2023 · DA

Florida Node Alliance of the Drug Abuse Clinic Trials Network

$483,942
Jose Szapocznik · University Of Miami School Of Medicine · U10 · FY2014 · DA

METHODOLOGY FOR DEVELOPING ADAPTIVE INTERVENTIONS

$483,931
Susan A Murphy · Pennsylvania State University, The · P50 · FY2008 · DA

Retinoic acid, homeostatic plasticity and cocaine craving

$483,892
Marina Elizabeth Wolf · Oregon Health & Science University · R01 · FY2021 · DA

Neural Analysis of Vocal Learning

$483,864
Michael S Brainard · University Of California, San Francisco · R01 · FY2014 · MH

Neural Analysis of Vocal Learning

$483,864
Michael S Brainard · University Of California, San Francisco · R01 · FY2015 · MH

Mechanisms driving lung cancer evolution during targeted kinase inhibitor treatment

$483,862
Aaron N Hata · Massachusetts General Hospital · R01 · FY2023 · CA

Non-addictive Angiotensin AT2 inhibitors for neuropathic pain relief

$483,858
Vsevolod Katritch · University Of Southern California · UG3 · FY2020 · NS

Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase

$483,851
Xinmin Simon Xie · Afasci, Inc. · U43 · FY2023 · AA

NEUROPHYSIOLOGY IN CHILDREN AT HIGH RISK FOR ALCOHOLISM

$483,832
Bernice Porjesz · Suny Downstate Medical Center · R37 · FY2008 · AA

Comparative Effectiveness and Feasibility of SBIRT in a General Dental Clinic

$483,723
Thomas F Babor · University Of Connecticut Sch Of Med/Dnt · RC1 · FY2010 · DE

Administrative Core

$483,700
Kimberly C Kirby · Treatment Research Institute · P50 · FY2012 · DA

Molecular Basis of Cannabinoid Activity

$483,666
Alexandros Makriyannis · Northeastern University · R01 · FY2013 · DA

EMPOWER: Evaluating the ability to reduce Morphine equivalent dose for chronic Pain patients receiving Opioid-therapy through a Web-based E-Health self-management program: a Randomized multi-site Clin

$483,640
T John Winhusen · University Of Cincinnati · R01 · FY2019 · DA

Therapeutic Community and Opioid Replacement Therapy

$483,627
University Of California San Francisco · R01 · FY2003 · DA